Last reviewed · How we verify

NCT07279389

Comparative Study Between One-Shot Dilatation Versus Serial Dilatation Techniques for Access in Percutaneous Nephrolithotomy in Adult Patients

Completed NA Last updated 12 December 2025
What this trial tests

NA trial testing renal dilatation by one-shot dilatation technique in Percutaneous Nephrolithotomy (PCNL) in 60 participants. Completed in 5 August 2023.

Timeline
27 February 2022
Primary endpoint
27 August 2022
5 August 2023

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date27 February 2022
Primary completion27 August 2022
Estimated completion5 August 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 70, any sex, with Percutaneous Nephrolithotomy (PCNL) or Renal Stone Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This comparative study aims to compare and assess the safety, efficacy, outcome, feasibility, intraoperative and postoperative complications of one-shot dilatation versus serial dilatation techniques for access during percutaneous nephrolithotomy for management of renal stone disease in adult patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Percutaneous Nephrolithotomy (PCNL)

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07279389.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing